Dr. Frueh was previously CSO at Human Longevity, Inc. He was the President of the Medco Research Institute and the first Associate Director for Genomics at FDA. In addition, he held executive positions in multiple biotechnology companies and serves on the Boards of several biotechnology corporations and non-profit organizations. Dr. Frueh is a Fellow of the American College of Clinical Pharmacology and held faculty positions at Georgetown University in Washington, DC and at the University of North Carolina.